Trial intelligence / Profile preview

Pioglitazone for Insulin Secretion in Type 2 Diabetes

NCT00656864Phase 4Completed

Sponsor
The University of Vermont
Start
May 2008
Primary completion
Nov 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by The University of Vermont. Started May 2008; status: completed.

02

Drugs

pioglitazone
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT00656864.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00656864.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call